Japanese pharmaceutical company Kowa says ivermectin showed an "antiviral effect" against Omicron and other variants of COVID-19.#COVID19 | #Ivermectin | #Coronavirushttps://t.co/KA4wc7bIK7— The Jerusalem Post (@Jerusalem_Post) January 31, 2022
Japanese pharmaceutical company Kowa says ivermectin showed an "antiviral effect" against Omicron and other variants of COVID-19.#COVID19 | #Ivermectin | #Coronavirushttps://t.co/KA4wc7bIK7